16 Out of 24 Health Care Companies Beat Topline Numbers This Week- Earnings Scorecard
Amgen First Quarter 2024 Earnings: EPS Misses Expectations
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
Promising weight loss candidates William Blair and Barclays raise AMGN.US ratings
Investment firm William Blair upgraded Amgen's stock rating to “outperform the market.” Barclays also raised Amgen's stock rating, from “reducing holdings” to “holding and watching.”
Top 20 Turnover | Apple surged 6% after announcing a $110 billion share repurchase plan
On Friday, Nvidia, No. 1 in terms of US stock turnover, closed 3.46% higher, with a transaction of US$35.189 billion; No. 2 Apple closed 5.98% higher, with a transaction of US$30.13 billion; and Tesla, number 3, closed 0.66% higher, with a transaction of US$13.683 billion.
US stocks closed | NASDAQ rose about 2%, Apple surged 6% after the results, and Nvidia rose more than 3%
The three major US stock indexes closed up at least 1%; Amgen led the S&P and Dow, the diet drug duo Lilai once fell more than 3%, and Novo Nord Europe shares once fell more than 5%; the chip stock index closed up more than 2% and still fell throughout the week. Qualcomm's sharp rise fell back the next day, and AMD earnings fell more than 4% in the week
Amgen(AMGN.US) Officer Sells US$662.8K in Common Stock
$Amgen(AMGN.US)$ Officer Grygiel Nancy A. sold 2,117 shares of common stock on May 3, 2024 at an average price of $313.0853 for a total value of $662.8K.Source: Announcement What is statement of chang
Form 144 | Amgen(AMGN.US) Officer Proposes to Sell 657.13K in Common Stocks
SEC FILLINGS DISCLOSED/ May 3, $Amgen(AMGN.US)$ Officer Nancy A. Grygiel intends to sell 2,117 shares of its common stock on May 3, with a total market value of approximately $657.13K. Source: Anno
These Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More -- Barrons.com
By Joe Woelfel and Connor Smith Stocks rose again on Friday after Apple's better-than-estimated earnings and on the latest jobs report, which showed the U.S. added fewer jobs than expected in April.
Apple Rally Helps Boost Equity Markets as Traders Parse Jobs Report
US benchmark equity indexes rallied Friday, aided by a post-earnings surge in Apple (AAPL) stock, as markets assessed weaker-than-expected jobs data. The technology-heavy Nasdaq Composite jumped 2% to
Stocks Rally As Jobs Report Rekindles Rate Cut Hopes, Apple Rockets, Bitcoin Soars Above $61,000: What's Driving Markets Friday?
A weaker-than-expected jobs report sparked a widespread market rally in the last session of the week, as traders increased expectations on potential interest rate cuts later this year.In April, nonfar
Slumping Payrolls Push US Equity Indexes Higher as Treasury Yields Sink
US equity indexes jumped after midday Friday as a steeper-than-expected drop in nonfarm payrolls sank government bond yields, spurring renewed speculation on prospects for interest-rate cuts. The S&P
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
US Equity Indexes Jump as Slumping Payrolls Instill Life Into Rate Cut Hopes
US equity indexes rose, while government bond yields dropped after midday Friday as a steeper-than-expected decline in nonfarm payrolls raised bets on interest rate cuts. The S&P 500 rose 1% to 5,112.
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
Wall Street's major indexes all jumped on the heels of a softer-than-expected jobs report released Friday by the US Department of Labor. In company news, Apple (AAPL) reported fiscal Q2 diluted earnin
Amgen Price Target Raised to $307.00/Share From $284.00 by UBS
Amgen Price Target Raised to $307.00/Share From $284.00 by UBS
Amgen Raised to Outperform From Market Perform by William Blair
Amgen Raised to Outperform From Market Perform by William Blair
Weight-loss Drug Competition Heats Up. Is Wegovy in Trouble?
Amgen Is Maintained at Outperform by BMO Capital
Amgen Is Maintained at Outperform by BMO Capital
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value
Amgen Inc (NASDAQ:AMGN) reported first-quarter (Q1) earnings Thursday, touting adjusted EPS of $3.96, which beat the analyst consensus estimate of $3.87.Here are highlights from the release and subseq
No Data